Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.120 | 9 | 122369409 | upstream gene variant | C/T | snv | 0.69 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.020 | 1.000 | 2 | 2014 | 2019 | |||||||
|
0.925 | 0.120 | 9 | 122369409 | upstream gene variant | C/T | snv | 0.69 |
|
Infections | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.040 | 9 | 122370243 | upstream gene variant | A/G | snv | 8.0E-02 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.776 | 0.200 | 9 | 122371228 | missense variant | C/T | snv | 5.9E-02 | 8.5E-02 |
|
Digestive System Diseases | 0.030 | 0.667 | 3 | 2006 | 2015 | ||||||
|
0.776 | 0.200 | 9 | 122371228 | missense variant | C/T | snv | 5.9E-02 | 8.5E-02 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.776 | 0.200 | 9 | 122371228 | missense variant | C/T | snv | 5.9E-02 | 8.5E-02 |
|
Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2011 | 2011 | ||||||
|
0.776 | 0.200 | 9 | 122371228 | missense variant | C/T | snv | 5.9E-02 | 8.5E-02 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
|
0.776 | 0.200 | 9 | 122371228 | missense variant | C/T | snv | 5.9E-02 | 8.5E-02 |
|
Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2011 | 2011 | ||||||
|
0.776 | 0.200 | 9 | 122371228 | missense variant | C/T | snv | 5.9E-02 | 8.5E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.776 | 0.200 | 9 | 122371228 | missense variant | C/T | snv | 5.9E-02 | 8.5E-02 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.776 | 0.200 | 9 | 122371228 | missense variant | C/T | snv | 5.9E-02 | 8.5E-02 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
|
0.776 | 0.200 | 9 | 122371228 | missense variant | C/T | snv | 5.9E-02 | 8.5E-02 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2004 | 2004 | ||||||
|
0.776 | 0.200 | 9 | 122371228 | missense variant | C/T | snv | 5.9E-02 | 8.5E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.776 | 0.200 | 9 | 122371228 | missense variant | C/T | snv | 5.9E-02 | 8.5E-02 |
|
Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2011 | 2011 | ||||||
|
1.000 | 0.080 | 9 | 122371825 | missense variant | C/T | snv | 7.8E-06 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
9 | 122372369 | intron variant | A/T | snv | 6.5E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
9 | 122372369 | intron variant | A/T | snv | 6.5E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
1.000 | 0.080 | 9 | 122374605 | intron variant | A/G | snv | 0.79 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
9 | 122375416 | 5 prime UTR variant | A/T | snv | 0.14 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||||
|
9 | 122376185 | intron variant | C/T | snv | 1.8E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
9 | 122376185 | intron variant | C/T | snv | 1.8E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
9 | 122376185 | intron variant | C/T | snv | 1.8E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
1.000 | 0.080 | 9 | 122377927 | splice acceptor variant | G/A | snv | 4.6E-02 | 9.5E-02 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.020 | 1.000 | 2 | 2011 | 2019 | ||||||
|
1.000 | 0.080 | 9 | 122378535 | missense variant | C/T | snv | 4.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
1.000 | 0.080 | 9 | 122378558 | missense variant | C/A;T | snv | 4.0E-06; 6.0E-05 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 |